Research Explores Cannabis as Treatment for MS, Alzheimer’s and Huntington’s Disease

Research Explores Cannabis as Treatment for MS, Alzheimer’s and Huntington’s Disease

Publication date: Jan 04, 2020

The research will examine whether CBD and other cannabinoids can relieve pain in patients with multiple sclerosis; if cannabis can reduce neuroinflammation and degeneration of the brain caused by Huntington’s disease; and if cannabinoids have neuroprotective activity in models of Alzheimer’s disease.

-Alzheimer’s disease, chronic pain, multiple sclerosis and Huntington’s disease are all devastating conditions that don’t have a lot of effective treatments,” said Tsuyuki.

In addition to its partnership with the U of A, Atlas is collaborating with Harvard Medical School in developing cannabis products for pain and other neurological conditions.

A recent study found that medical cannabis is mildly effective in relieving pain and other symptoms in patients with multiple sclerosis (MS).

Concepts Keywords
Alberta Active biological chemicals
Alzheimer News site
Bladder Cannabis products
Brain Huntington s disease
Canadian Mom cancer
Cancer Pain
Cannabidiol Numbness
Cannabinoids Friend illness
Cannabis MS
CBD Pain multiple sclerosis
Central Nervous System Drugs
Chief Operating Officer Medicine
Chronic Pain Entheogens
Clinical Trials Euphoriants
Edmonton Medicinal plants
Fatigue Appetite stimulants
Harvard Herbalism
Huntington Medical cannabis
Multiple Sclerosis Tetrahydrocannabinol
Neurological Effects of cannabis
Neuroprotective Cannabinoid


Type Source Name
disease MESH paralysis
disease MESH difficulty walking
disease MESH numbness
disease MESH muscle spasticity
disease MESH chronic pain
disease MESH multiple sclerosis
disease MESH cancer
drug DRUGBANK Cannabidiol
drug DRUGBANK Dronabinol
drug DRUGBANK Fenamole
drug DRUGBANK Medical Cannabis


Leave a Comment

Your email address will not be published. Required fields are marked *